A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
Clinical trial NCT06995573 · RECRUITING
Trial details
- NCT number
- NCT06995573
- Sponsor
- NSC-Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-25
- Primary completion
- 2026-07-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.